These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 13552313)

  • 1. [Behavior of peripheral utilization of glucose during treatment with hypoglycemic sulfonamides].
    INTROZZI P; MARIGO S
    Minerva Med; 1958 Apr; 49(31):1492-4. PubMed ID: 13552313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action of hypoglycemic sulfonamides. I. Effect of N'-sulfanilyl-N'-butyl urea (BZ 55) on protal, suprahepatic and peripheral arteriovenous blood sugar in dogs after administration of glucose].
    CIMINO S; BILLITTERI A; CALDARERA G
    Arch Sci Biol (Bologna); 1958; 42(5):432-46. PubMed ID: 13607155
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of hypoglycemic sulfonamides. II. Effect of N'-sulfanilyl-N'-butyl urea (BZ 55) on intestinal absorption of glucose.
    CIMINO S; CALDARERA G; BILLITTERI A
    Arch Sci Biol (Bologna); 1958; 42(5):447-52. PubMed ID: 13607156
    [No Abstract]   [Full Text] [Related]  

  • 4. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats.
    Choi SB; Jang JS; Park S
    Brain Res Bull; 2005 Sep; 67(1-2):77-86. PubMed ID: 16140165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hyperinsulinemia on amino acid utilization and oxidation independent of glucose metabolism in the ovine fetus.
    Brown LD; Hay WW
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1333-40. PubMed ID: 16868230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral glucose utilization after intravenous glucagon loading.
    SCHWAMM HA
    Helv Paediatr Acta; 1957 Oct; 12(4):361-74. PubMed ID: 13480674
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.
    Zhang HB; Zhang YA; Wu GZ; Zhou JP; Huang WL; Hu XW
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1740-4. PubMed ID: 19216076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral utilization of glucose in pregnancy. II. Preeclampsia.
    BURT RL
    Obstet Gynecol; 1955 Jul; 6(1):51-4. PubMed ID: 14394546
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats.
    Pathan AR; Viswanad B; Sonkusare SK; Ramarao P
    Life Sci; 2006 Nov; 79(23):2209-16. PubMed ID: 16904700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notes on behavior of glucide metabolism of diabetic dogs treated with the new hypoglycemic drugs.
    DE FRANCISCIS P; RUSSO N; BERNINI L; CAMPANELLI B
    Minerva Med; 1958 Apr; 49(31):1504. PubMed ID: 13552323
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats.
    Niu HS; Liu IM; Cheng JT; Lin CL; Hsu FL
    Planta Med; 2008 Feb; 74(2):109-13. PubMed ID: 18203055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma glucose lowering action of tetrandrine in streptozotocin-induced diabetic rats.
    Chen WC; Hayakawa S; Yamamoto T; Huang LW; Liu IM; Cheng JT
    J Pharm Pharmacol; 2004 May; 56(5):643-8. PubMed ID: 15142342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the gut-brain axis in the control of glucose homeostasis.
    Migrenne S; Marsollier N; Cruciani-Guglielmacci C; Magnan C
    Curr Opin Pharmacol; 2006 Dec; 6(6):592-7. PubMed ID: 16990049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relations between sulfonamides and sugar in blood and behavior of sulfonamides in normal anddiabetic subjects after administration of carbutamide].
    VITELLI A; GAIDANO G; MARTINO P; SIRACUSA F; VINAY L
    Minerva Med; 1958 Apr; 49(32):1509. PubMed ID: 13552330
    [No Abstract]   [Full Text] [Related]  

  • 18. The plasma glucose lowering action of Hei-Shug-Pian, the fire-processed product of the root of Aconitum (Aconitum carmichaeli), in streptozotocin-induced diabetic rats.
    Liou SS; Liu IM; Lai MC
    J Ethnopharmacol; 2006 Jun; 106(2):256-62. PubMed ID: 16443340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chi TC; Ho YJ; Chen WP; Chi TL; Lee SS; Cheng JT; Su MJ
    Life Sci; 2007 Apr; 80(20):1832-8. PubMed ID: 17397876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation in insulin-stimulated systemic glucose and amino acid utilization in pigs fed with identical meals at 12-hour intervals.
    Koopmans SJ; van der Meulen J; Dekker R; Corbijn H; Mroz Z
    Horm Metab Res; 2006 Sep; 38(9):607-13. PubMed ID: 16981145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.